Merck Acquires Chinese Biopharma Supplier

  • Author: ChemistryViews
  • Published: 05 January 2011
  • Associated Suppliers: Merck KGaA, Darmstadt, Germany
thumbnail image: Merck Acquires Chinese Biopharma Supplier

Merck KGaA has acquired 100 % of the share capital of Beijing Skywing Technology Co., Ltd., a leading supplier of cell-culture media products, related technical services and bioreactors for the Chinese biopharmaceutical industry.

The company is headquartered in the Changping district of Beijing and currently employs 80 people. The purchase price was CYN 120 million (approx. EUR 14 million).

The Chinese biopharmaceutical market is predicted to grow by 20 % over the next years, primarily driven by the local vaccine and antibody industries. Merck plan to utilize this access to the Chinese biopharmaceutical market to leverage Merck Millipore consumables sales like chromatography media, filtration devices and disposable bioreactor solutions.


Article Views: 3429

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH